Therapie zerebraler arteriovenöser Malformationen nach ARUBA – Pro

Die ARUBA-Studie [1] [2] [3] ist eine prospektive, multizentrische, kontrollierte Studie, die untersuchen sollte, ob die Behandlung zerebraler arteriovenöser Malformationen, die noch nicht geblutet haben, sinnvoll ist. In die Studie wurden Patienten mit arteriovenösen Malformationen eingeschlossen, die noch nicht geblutet hatten. Als kombinierter Studienendpunkt wurde Tod bzw. Schlaganfall genommen.

• Literatur

• 1 Mohr JP, Parides MK, Stapf C et al., international ARUBA investigators. Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial. Lancet 2014; 383: 614-621
• 2 Stapf C, Parides MK, Moskowitz AJ et al. Management of brain arteriovenous malformations – authors’ reply. Lancet 2014; 383: 1635-1636
• 3 Stapf C, Kummer R. Patients with unruptured brain AVM have no benefit from preventive surgery, interventional neuroradiology and/or radiotherapy. Akt Neurol im Druck
• 4 Sandalcioglu IE, Wanke I, Zappala V et al. The management of arteriovenous malformations. J Neurosurg Sci 2011; 55: 57-69
• 5 Meling TR, Proust F, Gruber A et al. On apples, oranges, and ARUBA. Acta Neurochir (Wien) 2014; 156: 1775-1779
• 6 Bradac O, Charvat F, Benes V. Treatment for brain arteriovenous malformation in the 1998–2011 period and review of the literature. Acta Neurochir 2013; 155: 199-209
• 7 Davies JM, Yanamadala V, Lawton MT. Comparative effectiveness of treatments for cerebral arteriovenous malformations: trends in nationwide outcomes from 2000 to 2009. Neurosurg Focus 2012; 33: E11
• 8 Laakso A, Dashti R, Juvela S et al. Risk of hemorrhage in patients with untreated Spetzler-Martin grade IV and V arteriovenous malformations: a long-term follow-up study in 63 patients. Neurosurgery 2011; 68: 372-378
• 9 Potts MB, Zumofen DW, Raz E et al. Curing arteriovenous malformations using embolization. Neurosurg Focus 2014; 37: E19
• 10 Theofanis T, Chalouhi N, Dalyai R et al. Microsurgery for cerebral arteriovenous malformations: postoperative outcomes and predictors of complications in 264 cases. Neurosurg Focus 2014; 37: E10
• 11 van Beijnum J, van der Worp HB, Buis DR et al. Treatment of brain arteriovenous malformations. A systematic review and meta-analysis. JAMA 2011; 306: 2011-2019
• 12 Bervini D, Morgan MK, Ritson EA et al. Surgery for unruptured arteriovenous malformations of the brain is better than conservative management for selected cases: a prospective cohort study. J Neurosurg 2014; 121: 878-890
• 13 Rutledge WC, Abla AA, Nelson J et al. Treatment and outcomes of ARUBA-eligible patients with unruptured brain arteriovenous malformations at a single institution. Neurosurg Focus 2014; 37: E8
• 14 Al-Shahi Salman R, White PM, Counsell CE et al. Outcome after conservative management or intervention for unruptured brain arteriovenous malformations. JAMA 2014; 311: 1661-1669
• 15 Abla AA, Lawton MT. Editorial: Prenidal aneurysm rupture with posterior fossa AVMs. Neurosurg Focus 2014; 37: E5
• 16 Flores BC, Klinger DR, Rickert KL et al. Management of intracranial aneurysms associated with arteriovenous malformations. Neurosurg Focus 2014; 37: E11
• 17 Kouznetsov E, Weill A, Ghostine JS et al. Association between posterior fossa arteriovenous malformations and prenidal aneurysm rupture: potential impact on management. Neurosurg Focus 2014; 37: E4
• 18 Kim H, Al-Shahi Salman R, McCulloch CE et al. Untreated brain arteriovenous malformation: Patient-level meta-analysis of hemorrhage predictors. Neurology 2014; 83: 590-597